181 related articles for article (PubMed ID: 37362434)
1. Dystrophic cardiomyopathy: role of the cardiac myofilaments.
George TG; Hanft LM; Krenz M; Domeier TL; McDonald KS
Front Physiol; 2023; 14():1207658. PubMed ID: 37362434
[TBL] [Abstract][Full Text] [Related]
2. Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart.
Haffner V; Nourian Z; Boerman EM; Lambert MD; Hanft LM; Krenz M; Baines CP; Duan D; McDonald KS; Domeier TL
Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1168-H1177. PubMed ID: 37737731
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
5. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
[TBL] [Abstract][Full Text] [Related]
7. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin treatment rescues abnormally reduced Na
Sauer J; Marksteiner J; Lilliu E; Hackl B; Todt H; Kubista H; Dostal C; Podesser BK; Kiss A; Koenig X; Hilber K
Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H418-H425. PubMed ID: 38099845
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy in Vivo.
Li J; Wang K; Zhang Y; Qi T; Yuan J; Zhang L; Qiu H; Wang J; Yang HT; Dai Y; Song Y; Chang X
Circulation; 2021 Nov; 144(22):1760-1776. PubMed ID: 34698513
[TBL] [Abstract][Full Text] [Related]
13. Calcium current properties in dystrophin-deficient ventricular cardiomyocytes from aged mdx mice.
Rubi L; Todt H; Kubista H; Koenig X; Hilber K
Physiol Rep; 2018 Jan; 6(1):. PubMed ID: 29333726
[TBL] [Abstract][Full Text] [Related]
14. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.
Koenig X; Rubi L; Obermair GJ; Cervenka R; Dang XB; Lukacs P; Kummer S; Bittner RE; Kubista H; Todt H; Hilber K
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H564-H573. PubMed ID: 24337461
[TBL] [Abstract][Full Text] [Related]
15. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
[TBL] [Abstract][Full Text] [Related]
16. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine acutely improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy.
Szabo PL; Marksteiner J; Ebner J; Dostal C; Podesser BK; Sauer J; Kubista H; Todt H; Hackl B; Koenig X; Kiss A; Hilber K
Physiol Rep; 2023 Apr; 11(7):e15664. PubMed ID: 37032434
[TBL] [Abstract][Full Text] [Related]
20. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Wasala NB; Bostick B; Yue Y; Duan D
Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
